Saturday, Sep 26, 2020 | Last Update : 04:28 PM IST

186th Day Of Lockdown

Maharashtra130045899280634761 Andhra Pradesh6614585881695606 Tamil Nadu5693705138369148 Karnataka5572124503028417 Uttar Pradesh3785333136865450 Delhi2644502284365147 West Bengal2410592110204665 Odisha201059165432820 Telangana1816271501601080 Bihar175898161510881 Assam167374136712625 Kerala160935111327636 Gujarat1303911105923394 Rajasthan1247301042881412 Haryana1205781012731273 Madhya Pradesh117588932382152 Punjab107096840253134 Chhatisgarh9856566860777 Jharkhand7770964515661 Jammu and Kashmir69832495571105 Uttarakhand4533233642555 Goa3107125071386 Puducherry2548919781494 Tripura2412717464262 Himachal Pradesh136799526152 Chandigarh112128677145 Manipur9791760263 Arunachal Pradesh8649623014 Nagaland5768469311 Meghalaya5158334343 Sikkim2707199431 Mizoram178612880
  Life   Health  03 Aug 2018  Transgender people more prone to heart disease risk, finds study

Transgender people more prone to heart disease risk, finds study

Published : Aug 3, 2018, 4:07 pm IST
Updated : Aug 3, 2018, 4:07 pm IST

Hormone therapy may be the reason why.

Representational Image. (Photo: Pixabay)
 Representational Image. (Photo: Pixabay)

Washington: According to a research, transgender individuals could be at higher risk for heart disease.

This increased risk may be due to the hormone therapy that transgender patients take for masculinisation or feminisation.


"Many transgender patients take either testosterone or estrogen for masculinization or feminization," explained Michael S. Irwig of George Washington University. "Some studies have suggested that transgender people have an increased risk for heart attack and death due to cardiovascular disease," added Irwig.

The review focuses on cardiovascular events (myocardial infarction, stroke and venous thromboembolism) and surrogate markers -- including blood pressure and lipid concentrations -- in transgender patients on hormone therapy who may or may not have undergone gender affirmation procedures.

The studies that the review covers show that transgender women appear to have increased risk of cardiovascular events due to hormone therapy whereas the data is unclear for transgender men. It is well known that estrogen therapy for trans-women increases their risk of blood clots (deep venous thromboses).


"In clinical studies that followed transgender patients, rates for myocardial infarction were consistently higher in transgender women on estrogen therapy than in transgender men on testosterone," Irwig said. "The relationship between endogenous sex hormones and heart disease is complex. In cisgender women, estrogen may have a protective effect," he explained further.

Given that hormone therapy is often essential in the management of transgender patients, Irwig suggested that more research is needed on the effects and risk of hormone therapy in older transgender populations and on the safest forms of estrogen therapy.

The study appears in the journal Reviews in Endocrine and Metabolic Disorders.


Tags: transgender, health, heart disease, hormone therapy